Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin

Bristol Myers Squibb is expanding its AI infrastructure by deploying a second NVIDIA DGX SuperPOD, referred to as the SuperDuperPOD. This initiative follows the success of one of the largest AI clusters in life sciences. Through this partnership with NVIDIA, the pharmaceutical giant aims to accelerate drug discovery. The implementation of this AI supercomputer has already demonstrated significant efficiency gains, specifically reducing computing costs by 55% as the company competes in the pharma industry AI race.